Issue of Share Options

18 Apr 2008 07:00

Immunodiagnostic Systems Hldgs PLC18 April 2008 Immunodiagnostic Systems Holdings plc ("IDS" or "the Company") Issue of Share Options The Board of IDS, a leading producer of diagnostic testing kits, announces thaton 25th March 2008, the following options to subscribe for ordinary shares of 2peach in the capital of the Company (the "Shares") were granted to: Employee Position Number of shares Exercise PriceMr. Ian Cookson Operations Director 333,617 189.5pMr. Alain Rousseau Engineering Director 133,446 189.5pMr. Edward Coombes Managing Director of IDS EURL 133,446 189.5pMr. Rudolf Schemer Managing Director of IDS GmbH 133,446 189.5pMiss Dagmar Casper Managing Director of IDS Nordic 133,446 189.5p Details of the options that have been granted are as follows: Options over 52,770 Shares exercisable at 189.5p per Share were granted to Mr.Ian Cookson under the Immunodiagnostic Systems Holdings plc EnterpriseManagement Initiative Share Option Scheme. The remaining options over 814,631 Shares exercisable at 189.5p per Share weregranted as unapproved options under an option agreement. None of the above named employees previously held any options over Shares. The exercise of options granted is subject to the achievement of certainperformance conditions set by the board and the options are exercisable over aperiod of three to ten years. Further details are provided on Page 50 of the2007 Annual Report. For further information please contact: Immunodiagnostic Systems Holdings plc Tel: 0191 519 0660Dr. Roger Duggan Mr. Paul Hailes Oriel Securities Limited (Nominated Adviser) Tel: 020 7710 7600Andrew Edwards Parkgreen Communications Tel: 020 7479 4933Lucy Lake Mob: 07894 263 046 This information is provided by RNS The company news service from the London Stock Exchange